Nasdaq

The ADRs of Australian biotech Kazia Therapeutics (NASDAQ:KZIA) gained 8% Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) granted the Rare Pediatric Disease Designation for an experimental therapy targeted at.

Tilray Brands (NASDAQ:TLRY) said its cannabis brand Good Supply expanded its product offering in Québec with the launch of Hash-Infused Pre-Rolls, in collaboration with the Société Québécoise du cannabis (SQDC). The infused pre-rolls offer an average THC level of ~26% with about 2/3 dried flower...

These stocks have fallen hard this year, despite underlying businesses that are in the right place at the right time.